Another important direction in the study of cannabinoids is the determination of possible breast cancer subpopulations most likely to respond positively to cannabinoid treatment, especially for tumors that are high in PD-L1 expression or have shown immunotherapy resistance (Stanowska et al., 2022). The gene discussed is CD274; the disease is breast carcinoma.